Public Meeting: Patient-Focused Drug Development for Fibromyalgia (Part 2 of 2)

Virtual Public Meeting on Patient-Focused Drug Development for Long COVIDПодробнее

Virtual Public Meeting on Patient-Focused Drug Development for Long COVID

Public Meeting on Patient Focused Drug Development for Narcolepsy Part 2Подробнее

Public Meeting on Patient Focused Drug Development for Narcolepsy Part 2

Public Meeting on Patient Focused Drug Development for HIV Part 2Подробнее

Public Meeting on Patient Focused Drug Development for HIV Part 2

Public Meeting on Patient Focused Drug Development for HIV Part 1Подробнее

Public Meeting on Patient Focused Drug Development for HIV Part 1

Public Meeting on Patient Focused Drug Development for Narcolepsy Part 1Подробнее

Public Meeting on Patient Focused Drug Development for Narcolepsy Part 1

Public Meeting on Patient Focused Drug Development for Inborn Errors of Metabolism Part 1Подробнее

Public Meeting on Patient Focused Drug Development for Inborn Errors of Metabolism Part 1

Public Meeting on Patient Focused Drug Development for Lung Cancer Part 1Подробнее

Public Meeting on Patient Focused Drug Development for Lung Cancer Part 1

Public Meeting on Patient Focused Drug Development for Pulmonary Arterial Hypertension Part 1Подробнее

Public Meeting on Patient Focused Drug Development for Pulmonary Arterial Hypertension Part 1

Juvenile Arthritis Patient-Focused Drug Development Meeting - Part 2Подробнее

Juvenile Arthritis Patient-Focused Drug Development Meeting - Part 2

Public Meeting: Patient-Focused Drug Development for Chronic Pain (Part 2)Подробнее

Public Meeting: Patient-Focused Drug Development for Chronic Pain (Part 2)

FDA Public Meeting for Patient-Focused Drug Development on Chronic Pain, 7/9/18: 1 of 2Подробнее

FDA Public Meeting for Patient-Focused Drug Development on Chronic Pain, 7/9/18: 1 of 2

Public Meeting on Patient Focused Drug Development for Idiopathic Pulmonary Fibrosis Part 1Подробнее

Public Meeting on Patient Focused Drug Development for Idiopathic Pulmonary Fibrosis Part 1

"Understanding the Drug Development Overview" - Webinar 1 of 2 NFMCPAПодробнее

'Understanding the Drug Development Overview' - Webinar 1 of 2 NFMCPA

Public Meeting on Patient Focused Drug Development for Psoriasis Part 2Подробнее

Public Meeting on Patient Focused Drug Development for Psoriasis Part 2

Public Meeting: Patient-Focused Drug Development for Systemic SclerosisПодробнее

Public Meeting: Patient-Focused Drug Development for Systemic Sclerosis

Public Meeting: Patient-Focused Drug Development for Neuropathic Pain (Part 2 of 3)Подробнее

Public Meeting: Patient-Focused Drug Development for Neuropathic Pain (Part 2 of 3)